Patent details

EP2152297 Title: UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS

Basic Information

Publication number:
EP2152297
PCT Application Number:
PCT/EP/2008/056727
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087603148
PCT Publication Number:
WO/2008/145749
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS
French Title of Invention:
GHRÉLINE NON ACYLÉE COMME AGENT THÉRAPEUTIQUE DANS LE TRAITEMENT DE TROUBLES MÉTABOLIQUES
German Title of Invention:
NICHT ACYLIERTES GHRELIN ALS THERAPEUTIKUM ZUR BEHANDLUNG VON STOFFWECHSELERKRANKUNGEN
SPC Number:

Dates

Filing date:
30/05/2008
Grant date:
29/04/2015
EP Publication Date:
29/04/2015
PCT Publication Date:
04/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/02/2010
EP B1 Publication Date:
29/04/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/05/2015
Expiration date:
30/05/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/05/2008
 
 

Name:
Alizé Pharma SAS
Address:
15, Chemin du Saquin, 69130 Ecully, France (FR)

Inventor

1

Name:
GHIGO Ezio
Address:
Italy (IT)

2

Name:
VAN DER LELY Aart, Jan
Address:
Netherlands (NL)

3

Name:
GRANATA Riccarda
Address:
Italy (IT)

Priority

Priority Number:
941186 P
Priority Date:
31/05/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/25;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages